Bladder cancer trials in Portugal
3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Lisbon, Porto
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1Not yet taking people in PortugalA phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
- Where
- Porto
- Age
- 18 years and over
- People
- 64 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-518348-19-00 · EU 2024-518348-19-00 - No phaseTaking peopleA Study to Characterize High-Risk Non-Muscle-Invasive Bladder Cancer Participants in Portugal
- Where
- Lisbon
- Age
- 18 years and over
- People
- 250
- Run by
- Janssen-Cilag Farmaceutica Ltda.
See details and how to joinNCT07784387